Q2 2023 Holdings
Filed 2023-08-14 | 48 holdings | $1.4B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Sinovac Biotech Ltd.(SVA) | SHS | P8696W104 | $615.4M | 5,900,000 | 42.5% |
| Harmony Biosciences Holdings Inc(HRMY) | Common | 413197104 | $91.7M | 2,606,247 | 6.3% |
| Verona Pharma PLC(VRNA) | ADS | 925050106 | $89.8M | 4,249,918 | 6.2% |
| Avadel Pharmaceuticals PLC | ADR | 05337M104 | $63.1M | 3,829,577 | 4.4% |
| Terns Pharmaceuticals Inc(TERN) | Common | 880881107 | $58.3M | 6,657,992 | 4.0% |
| Geron Corp(GERN) | Common | 374163103 | $53.0M | 16,524,634 | 3.7% |
| Tarsus Pharmaceuticals Inc(TARS) | Common | 87650L103 | $40.9M | 2,262,200 | 2.8% |
| Viridian Therapeutics Inc(VRDN) | Common | 92790C104 | $39.9M | 1,678,207 | 2.8% |
| VectivBio Holding AG | Common | H9060V101 | $39.4M | 2,333,300 | 2.7% |
| Chinook Therapeutics Inc(290A) | Common | 16961L106 | $35.9M | 934,879 | 2.5% |
| ALX Oncology Holdings Inc(ALXO) | Common | 00166B105 | $31.7M | 4,220,048 | 2.2% |
| Cogent Biosciences Inc(COGT) | Common | 19240Q201 | $26.6M | 2,244,941 | 1.8% |
| Icosavax, Inc. | Common | 45114M109 | $16.9M | 1,704,568 | 1.2% |
| Gracell Biotechnologies Inc | SPONSORED ADS | 38406L103 | $15.1M | 3,969,427 | 1.0% |
| Astria Therapeutics Inc(CATBUSD) | Common | 04635X102 | $14.0M | 1,681,199 | 1.0% |
| Ventyx Biosciences Inc(VTYX) | Common | 92332V107 | $13.8M | 422,075 | 1.0% |
| Arcellx Inc.(ACLX) | Common | 03940C100 | $13.7M | 433,785 | 0.9% |
| Allakos Inc(ALLKGUSD) | Common | 01671P100 | $13.0M | 2,988,000 | 0.9% |
| Zai Lab Ltd ADR(ZLAB) | ADR | 98887Q104 | $12.4M | 445,505 | 0.9% |
| Olema Pharmaceuticals Inc(OLMA) | Common | 68062P106 | $12.1M | 1,339,271 | 0.8% |
| Verastem Inc(VSTM) | Common | 92337C203 | $11.4M | 1,538,461 | 0.8% |
| Compass Therapeutics Inc(CMPX) | Common | 20454B104 | $11.3M | 3,556,023 | 0.8% |
| Aslan Pharmaceuticals Ltd | ADS | 04522R101 | $10.4M | 2,840,908 | 0.7% |
| Alpine Immune Sciences Inc(NVLSEUR) | Common | 02083G100 | $9.4M | 914,913 | 0.6% |
| Aclaris Therapeutics, Inc.(ACRS) | Common | 00461U105 | $9.3M | 898,631 | 0.6% |
| Amyris, Inc(AMRSEUR) | Common | 03236M200 | $8.0M | 7,750,828 | 0.6% |
| KalVista Pharmaceuticals Inc.(KALV) | Common | 483497103 | $7.7M | 856,008 | 0.5% |
| Genetron Holdings Ltd | ADS | 37186H100 | $7.6M | 8,124,174 | 0.5% |
| Instil Bio Inc | Common | 45783C101 | $6.9M | 12,486,787 | 0.5% |
| Delcath Systems, Inc.(DCTH) | Common | 24661P807 | $6.9M | 1,178,787 | 0.5% |
| Dyne Therapeutics Inc(DYN) | Common | 26818M108 | $6.5M | 577,642 | 0.4% |
| Aadi Bioscience Inc(WHWK) | Common | 00032Q104 | $6.5M | 509,572 | 0.4% |
| Sera Prognostics Inc(SERA) | Common | 81749D107 | $6.1M | 1,856,011 | 0.4% |
| IO Biotech Inc(IOBT) | Common | 449778109 | $5.9M | 3,015,545 | 0.4% |
| DBV Technologies SA | Sponsored ADR | 23306J101 | $5.1M | 2,708,875 | 0.4% |
| Bolt Therapeutics Inc(BOLT1EUR) | Common | 097702104 | $5.0M | 3,871,291 | 0.3% |
| Arrowhead Pharmaceuticals Inc(ARWR) | Common | 04280A100 | $4.9M | 137,411 | 0.3% |
| Iovance Biotherapeutics Inc(IOVA) | Common | 462260100 | $4.6M | 655,057 | 0.3% |
| Clene Inc(CLNNEUR) | Common | 185634102 | $3.7M | 4,520,622 | 0.3% |
| Impel NeuroPharma Inc | Common | 45258K109 | $3.7M | 2,884,789 | 0.3% |
| Aligos Therapeutics Inc | Common | 01626L105 | $3.4M | 3,547,030 | 0.2% |
| BioAtla Inc(BCAB) | Common | 09077B104 | $1.9M | 637,181 | 0.1% |
| Fulcrum Therapeutics Inc(FULC) | Common | 359616109 | $1.8M | 550,000 | 0.1% |
| Immunic Inc(IMUX) | Common | 4525EP101 | $1.6M | 632,184 | 0.1% |
| Codexis, Inc(CDXS) | Common | 192005106 | $1.1M | 388,144 | 0.1% |
| Rezolute Inc(RZLT) | Common | 76200L309 | $969.2K | 489,473 | 0.1% |
| Homology Medicines, Inc. | Common | 438083107 | $327.5K | 370,068 | 0.0% |
| Precision Biosciences Inc | Common | 74019P108 | $73.8K | 140,255 | 0.0% |